AstraZeneca ovarian cancer drug wins European green light
October 24, 2014 at 07:11 AM EDT
LONDON, Oct 24 (Reuters) - AstraZeneca's cancer drug pipeline received a boost on Friday as European regulators recommended approval of an experimental medicine against ovarian cancer.
